Finance Business Partner R&D

Argenx


Job Location:

Gent - Belgium

Monthly Salary: € 100000 - 137500
Posted on: 10 days ago
Vacancies: 1 Vacancy

Job Summary

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG and with the potential to treat patients across dozens of severe autoimmune diseases.


We are building a new kind of biotech company one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company our partnerships our science and our people because when we do we deliver more for patients.

As Finance Business Partner you will serve as a true strategic finance partner to our Chemistry Manufacturing & Controls (CMC) and Asset development teams where you will translate complex drug development activity into financial clarity and help make better faster decisions.

For this role we are looking for candidates based in Belgium or in Switzerland with the expectation that Switzerland-based hires visit our Belgian site around once per month.

WHAT YOU WILL DO

Strategic Business Partnering

  • Act as the primary finance business partner for TechOps/CMC and Asset development teams building trusted relationships and providing decision-relevant financial perspective.

  • Translate R&D strategy and pipeline milestones into financial plans forecasts and scenario analyses that guide investment decisions.

  • Proactively flag risks and opportunities offering financially sound recommendations rather than simply reporting variances.

Financial Planning & Forecasting

  • Own the end-to-end budgeting forecasting and long-range planning processes for assigned R&D functions.

  • Build and maintain robust financial models that reflect the realities of drug development including clinical milestones manufacturing scale-up regulatory timelines and external spend.

  • Partner with PMO Procurement and Alliance Management to ensure accurate accruals and PO management for CRO CMO and other R&D vendor contracts.

  • Monitor actuals vs. plan provide meaningful variance commentary and continuously improve forecast accuracy.

Insights & Analytics

  • Develop dashboards KPI scorecards and financial narratives that give R&D leadership a clear real-time view of financial performance.

  • Apply analytical rigour to answer business questions from program-level cost-per-patient analyses to portfolio prioritisation trade-offs.

  • Leverage argenxs Oracle EPM/PPM ecosystem and emerging AI/data tools to drive efficiency and elevate analytical depth.

Cross-functional Collaboration

  • Represent Finance in CMC programme reviews Asset meetings and project governance forums.

  • Collaborate closely with the broader FP&A team (R&D Corporate) and the R&D FP&A Lead to ensure consolidated financial coherence.

  • Support with ad hoc analyses and special projects.

  • Drive automation and AI adoption in day-to-day operations.

WHAT DO YOU BRING

Experience & Knowledge

  • 8 years of progressive FP&A or finance business partnering experience with meaningful time in pharma biotech or life sciences.

  • Deep working knowledge of the drug development process from IND-enabling studies through Phase IIII CMC scale-up regulatory submissions and launch readiness.

  • Proven track record as a finance partner who influences decisions not just supports reporting.

  • Experience managing complex R&D budgets including CRO/CDMO contracts milestone-based payments and accrual methodologies.

  • Proficiency with EPM/ERP tools (Oracle EPM/PPM a strong plus) and advanced Excel financial modelling.

  • Masters degree in Finance Economics Accounting or equivalent; CPA/CIMA/CFA qualification is a plus.

Mindset & Ways of Working

  • Curiosity-driven you ask why not just what. You want to understand the science strategy and operational context behind the numbers.

  • Analytical rigour paired with the ability to communicate complexity simply to senior non-finance stakeholders.

  • Comfortable operating in ambiguity and fast-paced environments; self-directed and proactive.

  • Collaborative by nature you actively build relationships across functions and bring others along.

  • High standards for output quality and attention to detail without losing sight of the bigger picture.

#LI-Hybrid


The annual base salary hiring range for this position is 100000.00 - 137500.00 EUR

This job is eligible to participate in our short-term and long-term incentives program.

The hiring range displayed above is the range of possible base pay compensation that argenx believes in good faith it will pay for this role at the time of this posting. The hiring range is based on the job grade for this position. Individual compensation paid within this range depends on a variety of factors including but not limited to internal equity prior education and experience job-related knowledge and demonstrated skills. argenx may pay more or less than the posted range and this range may be modified in the future.


At argenx all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race color religion sex sexual orientation gender identity national origin protected veteran status disability or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.


Before you submit your application CV or any other personal details to us please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (argenx) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights please contact our Global Privacy Office by email at .

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our first-in-class neonatal Fc receptor blocker appr...

About Company

Company Logo

Reaching Patients Through Immunology Innovation

View Profile View Profile